Prospective evaluation of regorafenib dose escalation strategy with low starting dose in patients with colorectal cancer

T. Masuishi; T. Suzuki; Y. Sukawa; C. K. Imamura; H. Satake; Y. Kumekawa; S. Funakoshi; M. Kotaka; Y. Horie; S. Kawai; H. Okuda; T. Terazawa; C. Kondoh; K. Kato; K. Yoshimura; H. Ishikawa; Y. Hamamoto; N. Boku; T. Kanai; H. Takaishi

doi:10.1093/annonc/mdy281.015

Prospective evaluation of regorafenib dose escalation strategy with low starting dose in patients with colorectal cancer

T. Masuishi, T. Suzuki, Y. Sukawa, C. K. Imamura, H. Satake, Y. Kumekawa, S. Funakoshi, M. Kotaka, Y. Horie, S. Kawai, H. Okuda, T. Terazawa, C. Kondoh, K. Kato, K. Yoshimura, H. Ishikawa, Y. Hamamoto, N. Boku, T. Kanai, H. Takaishi

Oncology Center

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	viii156
Journal	Annals of oncology : official journal of the European Society for Medical Oncology
Volume	29
DOIs	https://doi.org/10.1093/annonc/mdy281.015
Publication status	Published - 2018 Oct 1

ASJC Scopus subject areas

Hematology
Oncology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/annonc/mdy281.015

Cite this

Masuishi, T., Suzuki, T., Sukawa, Y., Imamura, C. K., Satake, H., Kumekawa, Y., Funakoshi, S., Kotaka, M., Horie, Y., Kawai, S., Okuda, H., Terazawa, T., Kondoh, C., Kato, K., Yoshimura, K., Ishikawa, H., Hamamoto, Y., Boku, N., Kanai, T., & Takaishi, H. (2018). Prospective evaluation of regorafenib dose escalation strategy with low starting dose in patients with colorectal cancer. Annals of oncology : official journal of the European Society for Medical Oncology, 29, viii156. https://doi.org/10.1093/annonc/mdy281.015

Masuishi, T, Suzuki, T, Sukawa, Y, Imamura, CK, Satake, H, Kumekawa, Y, Funakoshi, S, Kotaka, M, Horie, Y, Kawai, S, Okuda, H, Terazawa, T, Kondoh, C, Kato, K, Yoshimura, K, Ishikawa, H, Hamamoto, Y, Boku, N, Kanai, T & Takaishi, H 2018, 'Prospective evaluation of regorafenib dose escalation strategy with low starting dose in patients with colorectal cancer', Annals of oncology : official journal of the European Society for Medical Oncology, vol. 29, pp. viii156. https://doi.org/10.1093/annonc/mdy281.015

@article{aa82538a20194bdb9b649281da69f9d7,

title = "Prospective evaluation of regorafenib dose escalation strategy with low starting dose in patients with colorectal cancer",

author = "T. Masuishi and T. Suzuki and Y. Sukawa and Imamura, {C. K.} and H. Satake and Y. Kumekawa and S. Funakoshi and M. Kotaka and Y. Horie and S. Kawai and H. Okuda and T. Terazawa and C. Kondoh and K. Kato and K. Yoshimura and H. Ishikawa and Y. Hamamoto and N. Boku and T. Kanai and H. Takaishi",

year = "2018",

month = oct,

day = "1",

doi = "10.1093/annonc/mdy281.015",

language = "English",

volume = "29",

pages = "viii156",

journal = "Annals of oncology : official journal of the European Society for Medical Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

}

TY - JOUR

T1 - Prospective evaluation of regorafenib dose escalation strategy with low starting dose in patients with colorectal cancer

AU - Masuishi, T.

AU - Suzuki, T.

AU - Sukawa, Y.

AU - Imamura, C. K.

AU - Satake, H.

AU - Kumekawa, Y.

AU - Funakoshi, S.

AU - Kotaka, M.

AU - Horie, Y.

AU - Kawai, S.

AU - Okuda, H.

AU - Terazawa, T.

AU - Kondoh, C.

AU - Kato, K.

AU - Yoshimura, K.

AU - Ishikawa, H.

AU - Hamamoto, Y.

AU - Boku, N.

AU - Kanai, T.

AU - Takaishi, H.

PY - 2018/10/1

Y1 - 2018/10/1

UR - http://www.scopus.com/inward/record.url?scp=85081528265&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85081528265&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdy281.015

DO - 10.1093/annonc/mdy281.015

M3 - Article

C2 - 32136263

SN - 0923-7534

VL - 29

SP - viii156

JO - Annals of oncology : official journal of the European Society for Medical Oncology

JF - Annals of oncology : official journal of the European Society for Medical Oncology

ER -

Prospective evaluation of regorafenib dose escalation strategy with low starting dose in patients with colorectal cancer

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this